Program
Monday 22nd May |
|
|---|---|
| 08:30 | Registration and coffee |
| 09:00 | Introduction and welcome |
| 09:10 | Keynote address: Microfluidic probe for multi-modal cancer diagnostics Dr. Aditya Kashyap, IBM Research, Zurich |
| Session: Sensors for molecular to cellular biomarkers | |
| 10:00 | Electrochemically activated templated reactions for detecting circulating RNA Dr. Danny O'Hare, Imperial College, London |
| 10:30 | Superselective glycan recognition as a powerful diagnostic tool for cancer detection Dr Stefano Tommasone, University of Birmingham |
| 11:00 | Coffee break |
| 11:30 | Bio-inspired Sensors for Better Cancer Diagnosis |
| 12:00 | Using opto-magnetic imaging spectroscopy and artificial intelligence to diagnose cancer Aamir Butt, Tumourtrace |
| 12:30 | |
| 13:00 | Lunch |
| Session: VOC Sensors | |
| 14:00 | Detection of cancer through gas phase biomarkers Dr. James Covington, University of Warwick |
| 14:40 | Breath Biopsy for Early Stage Cancer Detection Dr. Mike Murphy, Owlstone Medical |
| 15:05 | |
| 15:30 | Tea break |
| 16:00 | Screening, early detection, diagnostic pathways in cancer Dr. Fiona Walter, University of Cambridge |
| 16:45 | Panel discussion: Will sensor technology have a role in cancer therapy? |
| 18:00 | Networking reception: open bar |
| 20:00 | Reception ends |
Tuesday 23rd May 2017 |
|
| 08:30 | Registration and coffee |
| 09:00 | Introduction and welcome |
| 09:10 | Keynote address: Testing Times: Progress and challenges in achieving earlier diagnosis of cancer Sara Bainbridge, CRUK |
| Session: Liquid biopsy | |
| 10:00 | Targeted circulating tumour DNA profiling in early stage lung cancer Dr. Chris Abbosh, Francis Crick Institute |
| 10:30 | |
| 11:00 | Coffee break |
| Session: NGS for cancer diagnosis | |
| 11:30 | Reinventing liquid biopsy research using Next Generation Sequencing Chris Allen, ThermoFisher |
| 12:15 | Pending |
| 13:00 | Lunch |
| Session: Barriers to adopting new technology | |
| 14:00 | Bridging the gap between biosensor invention and biosensor commercialisation Dr. Martin Peacock, Zimmer and Peacock |
| 14:45 | Tea break |
| 15:15 | BioSensors for cancer diagnosis – reality or dream Dr. Michael Brand, Sensor100 |
| 16:00 | Discussion: The role of the Cancer Diagnostic Network |
| 17:00 | Conference ends |